EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 335 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $571,000 | -17.8% | 32,300 | -0.7% | 0.02% | -19.2% |
Q2 2019 | $695,000 | -5.2% | 32,543 | +5.7% | 0.03% | -13.3% |
Q1 2019 | $733,000 | +26.8% | 30,800 | +4.8% | 0.03% | +15.4% |
Q4 2018 | $578,000 | +19.2% | 29,400 | +7.3% | 0.03% | +44.4% |
Q3 2018 | $485,000 | +83.7% | 27,400 | +151.6% | 0.02% | +50.0% |
Q3 2017 | $264,000 | – | 10,890 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |